TheEdgeResearch
Home / Stocks / AXRX

Amexdrug Corporation (AXRX)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$33,882
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.55
52-Wk Range
0.0002-0.0002
CEO
Jack Amin
Country
US
Currency
USD

Amexdrug Corporation operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Commerce, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $33,882. On trailing twelve-month figures it carries a trailing P/E of 0.50, a net margin of 1.6%. Its beta of -0.55 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
0.50
Price / Sales
0.01
Price / Book
0.02
EV / EBITDA
2.63
Gross margin
38.5%
Operating margin
5.3%
Net margin
1.6%
Return on equity
Debt / equity
0.23
Current ratio
15.30
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
9
IPO date
2001-03-29
Headquarters
Commerce, CA, US
About Amexdrug Corporation

Amexdrug Corporation, founded in 1963 and headquartered in Commerce, California, operates as a pharmaceutical and cosmeceutical enterprise. Primarily, the company, via its subsidiaries, distributes pharmaceutical products. Beyond this core function, Amexdrug is also deeply involved in the entire lifecycle of pharmaceutical drugs, cosmetics, and medical devices, from their research and development phases through manufacturing and ultimate sale. The company's operations are divided into two main divisions: Distribution and Health and Beauty Products. Its extensive distribution network encompasses a wide range of items, including prescription and over-the-counter medications, various non-drug products, and health and beauty essentials. Amexdrug also provides services in private manufacturing and labeling. Specific product lines manufactured and sold by the company, often under its Sponix brand, include facial and body creams, arthritic pain relief treatments, and hair and nail care products. These goods are supplied to a diverse clientele such as pharmacies, beauty salons, beauty supply outlets, and other retail establishments. Within the state of California, Amexdrug's distribution channels primarily target independent pharmacies, extending secondarily to smaller pharmacy chains, alternative care facilities, and various wholesalers and retailers. The company adopted the name Amexdrug Corporation in April 2000, changing from its previous identity as Harlyn Products, Inc., to reflect its strategic focus on pharmaceutical sales.

Comparable companies

Amexdrug Corporation is most often compared with the following Healthcare names:

CBDXIHTIMLPHNSRSPRCNFPSIQPZOORLBDTNPHWSRC
More research on AXRX
AXRX technical analysis AXRX TheEdge Score Compare against peers
Open full interactive analysis & DCF →